Journal Club – Safety & Efficacy Review of IPX203

This Journal Club is an opportunity to dig in to the data and better understand the newest FDA-approved treatment for Parkinson’s, CREXONT!  This novel therapy is anticipated to be a game changer!  This Journal Club will be facilitated by expert faculty: Stuart Isaacson, MD, FAAN and Randi Loomis, MSN, ARNP, FNP-BC from the Parkinson’s Disease and Movement Disorders Center in Boca Raton, FL. Together they have managed patients enrolled in the IPX203 clinical trials!  

Register below!